Combination therapies for previously untreated CLL

被引：1
|
作者：
Shanafelt, Tait D. [1 ]
Kay, Neil E. [1 ]
机构：
[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA
来源：
LANCET | 2007年 / 370卷 / 9583期
关键词：
D O I：
10.1016/S0140-6736(07)61100-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：197 / 198
页数：2
相关论文
共 50 条
  • [31] Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study
    Stephan Stilgenbauer
    Veronique Leblond
    Robin Foà
    Sebastian Böttcher
    Osman Ilhan
    Wolfgang Knauf
    Eva Mikuskova
    Christoph Renner
    Eugen Tausch
    Dariusz Woszczyk
    Ekaterina Gresko
    Linda Lundberg
    Tom Moore
    Thea Morris
    Susan Robson
    Francesc Bosch
    Leukemia, 2018, 32 : 1778 - 1786
  • [32] Lendalidomide Consolidation After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL
    Shanafelt, Tait
    Tun, Han
    Hanson, Curtis
    Zent, Clive S.
    Leis, Jose
    Call, Timothy
    LaPlant, Betsy
    Bowen, Deborah
    Laumann, Kristina
    Jelinek, Diane F.
    Kay, Neil E.
    BLOOD, 2010, 116 (21) : 593 - 593
  • [33] A Phase II Stud of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Xu, Wei
    Kukreti, Vishal
    Trudel, Suzanne
    Wei, Ellen
    Li, Zhi Hua
    Brandwein, Joseph
    Pantoja, Mariela
    Leung-Hagensteijn, Chungyee
    BLOOD, 2008, 112 (11) : 23 - 23
  • [34] Oral fludarabine and cyclophosphamide in previously untreated CLL: Preliminary data on 75 pts.
    Cazin, B
    Maloum, K
    Divine, M
    Lepretre, S
    Travade, P
    Delmer, A
    Jaubert, J
    Lederlin, P
    Dreyfus, B
    Leporrier, M
    Harousseau, IL
    Grosbois, B
    Maloisel, F
    Eghbali, H
    Dumontet, C
    Guyotat, D
    Benichou, J
    Guibon, O
    BLOOD, 2002, 100 (11) : 206A - 206A
  • [35] An Open-Label Phase 2 Study of Lenalidomide in Combination with Oral Dexamethasone in the Previously Untreated, Symptomatic Patients with Chronic Lymphocytic Leukemia (CLL)
    Chen, Christine
    Paul, Harminder
    Del Rizzo, Luisa
    Le, Lisa W.
    Wei, Ellen Nong
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Brown, Michelle
    Trudel, Suzanne
    BLOOD, 2012, 120 (21)
  • [36] Combined Venetoclax and Ibrutinib for Patients with Previously Untreated High-Risk CLL, and Relapsed/Refractory CLL: A Phase II Trial
    Jain, Nitin
    Thompson, Philip A.
    Ferrajoli, Alessandra
    Burger, Jan A.
    Borthakur, Gautam
    Takahashi, Koichi
    Bose, Prithviraj
    Estrov, Zeev
    Jabbour, Elias J.
    Konopleva, Marina
    Alvarado, Yesid
    Kadia, Tapan
    Yilmaz, Musa
    DiNardo, Courtney D.
    Ohanian, Maro
    Cortes, Jorge E.
    Kanagal-Shamanna, Rashmi
    Patel, Keyur
    Garg, Naveen
    Wang, Xuemei
    Fru, Nina
    Cruz, Nichole
    Gandhi, Varsha
    Plunkett, William
    Kantarjian, Hagop M.
    Keating, Michael J.
    Wierda, William G.
    BLOOD, 2017, 130
  • [37] Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib
    Ahn, Inhye E.
    Jerussi, Theresa
    Farooqui, Mohammed
    Tian, Xin
    Wiestner, Adrian
    Gea-Banacloche, Juan
    BLOOD, 2016, 128 (15) : 1940 - 1943
  • [38] A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia
    Cheng, Mindy M.
    Goulart, Bernardo
    Veenstra, David L.
    Blough, David K.
    Devine, Emily Beth
    CANCER TREATMENT REVIEWS, 2012, 38 (08) : 1004 - 1011
  • [39] Results of the randomized phase IIB ADMIRE trial of FCR with or without mitoxantrone in previously untreated CLL
    Munir, T.
    Howard, D. R.
    McParland, L.
    Pocock, C.
    Rawstron, A. C.
    Hockaday, A.
    Varghese, A.
    Hamblin, M.
    Bloor, A.
    Pettitt, A.
    Fegan, C.
    Blundell, J.
    Gribben, J. G.
    Phillips, D.
    Hillmen, P.
    LEUKEMIA, 2017, 31 (10) : 2085 - 2093
  • [40] A phase 2 study of lenalidomide and dexamethasone in previously untreated patients with chronic lymphocytic leukemia (CLL)
    Chen, Christine I.
    Paul, Harminder
    Snitzler, Susi
    Kakar, Sumeet
    Le, Lisa W.
    Wei, Ellen N.
    Lau, Anthea
    Johnston, James B.
    Gibson, Spencer B.
    Queau, Michelle
    Spaner, David
    Croucher, Danielle
    Sherry, Barbara
    Trudel, Suzanne
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 980 - 989
12345